10x Genomics (TXG) Competitors $14.11 +0.38 (+2.77%) Closing price 04:00 PM EasternExtended Trading$14.20 +0.10 (+0.67%) As of 05:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TXG vs. ADPT, PACB, TWST, VCYT, VNT, RAL, MIR, ST, CAMT, and TRNSShould you be buying 10x Genomics stock or one of its competitors? The main competitors of 10x Genomics include Adaptive Biotechnologies (ADPT), Pacific Biosciences of California (PACB), Twist Bioscience (TWST), Veracyte (VCYT), Vontier (VNT), Ralliant (RAL), Mirion Technologies (MIR), Sensata Technologies (ST), Camtek (CAMT), and Transcat (TRNS). 10x Genomics vs. Its Competitors Adaptive Biotechnologies Pacific Biosciences of California Twist Bioscience Veracyte Vontier Ralliant Mirion Technologies Sensata Technologies Camtek Transcat Adaptive Biotechnologies (NASDAQ:ADPT) and 10x Genomics (NASDAQ:TXG) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations, media sentiment and institutional ownership. Is ADPT or TXG more profitable? 10x Genomics has a net margin of -25.14% compared to Adaptive Biotechnologies' net margin of -74.84%. 10x Genomics' return on equity of -23.22% beat Adaptive Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets Adaptive Biotechnologies-74.84% -62.79% -24.55% 10x Genomics -25.14%-23.22%-18.02% Which has more volatility & risk, ADPT or TXG? Adaptive Biotechnologies has a beta of 1.83, indicating that its stock price is 83% more volatile than the S&P 500. Comparatively, 10x Genomics has a beta of 2.03, indicating that its stock price is 103% more volatile than the S&P 500. Do institutionals and insiders believe in ADPT or TXG? 99.2% of Adaptive Biotechnologies shares are held by institutional investors. Comparatively, 84.7% of 10x Genomics shares are held by institutional investors. 6.4% of Adaptive Biotechnologies shares are held by insiders. Comparatively, 9.4% of 10x Genomics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has higher earnings & valuation, ADPT or TXG? Adaptive Biotechnologies has higher earnings, but lower revenue than 10x Genomics. Adaptive Biotechnologies is trading at a lower price-to-earnings ratio than 10x Genomics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdaptive Biotechnologies$189.53M8.62-$159.49M-$0.96-11.2010x Genomics$610.78M2.84-$182.63M-$1.30-10.85 Do analysts prefer ADPT or TXG? Adaptive Biotechnologies presently has a consensus target price of $10.57, indicating a potential downside of 1.66%. 10x Genomics has a consensus target price of $13.23, indicating a potential downside of 6.26%. Given Adaptive Biotechnologies' stronger consensus rating and higher possible upside, equities analysts clearly believe Adaptive Biotechnologies is more favorable than 10x Genomics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adaptive Biotechnologies 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.8610x Genomics 1 Sell rating(s) 5 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.42 Does the media refer more to ADPT or TXG? In the previous week, 10x Genomics had 1 more articles in the media than Adaptive Biotechnologies. MarketBeat recorded 10 mentions for 10x Genomics and 9 mentions for Adaptive Biotechnologies. Adaptive Biotechnologies' average media sentiment score of 1.07 beat 10x Genomics' score of 1.04 indicating that Adaptive Biotechnologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adaptive Biotechnologies 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive 10x Genomics 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Summary10x Genomics beats Adaptive Biotechnologies on 8 of the 15 factors compared between the two stocks. Get 10x Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TXG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TXG vs. The Competition Export to ExcelMetric10x GenomicsMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.74B$2.11B$5.74B$9.51BDividend YieldN/AN/A4.60%3.99%P/E Ratio-10.8537.0828.0820.03Price / Sales2.8410.85460.87103.88Price / CashN/A56.5036.5559.01Price / Book2.439.108.645.90Net Income-$182.63M-$63.59M$3.24B$258.66M7 Day Performance16.13%3.27%4.11%2.20%1 Month Performance21.01%12.34%10.74%12.75%1 Year Performance-29.17%7.60%34.43%19.27% 10x Genomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TXG10x Genomics4.1353 of 5 stars$14.11+2.8%$13.23-6.3%-27.6%$1.74B$610.78M-10.851,240Positive NewsADPTAdaptive Biotechnologies2.7826 of 5 stars$10.31-0.8%$10.57+2.5%+155.6%$1.57B$178.96M-10.74790Positive NewsPACBPacific Biosciences of California1.7164 of 5 stars$1.45+5.8%$2.06+42.1%-18.1%$435.12M$154.01M-0.52730Positive NewsTWSTTwist Bioscience4.3689 of 5 stars$34.77-1.1%$50.40+45.0%-37.4%$2.08B$312.97M-10.70990Positive NewsVCYTVeracyte3.6646 of 5 stars$23.03-2.0%$40.90+77.6%+0.7%$1.80B$445.76M56.17790Positive NewsGap UpVNTVontier3.974 of 5 stars$38.08-0.9%$46.33+21.7%+0.9%$5.63B$2.98B15.488,000News CoveragePositive NewsUpcoming EarningsRALRalliantN/A$46.620.0%$57.25+22.8%N/A$5.27BN/A0.007,000Analyst ForecastMIRMirion Technologies1.0236 of 5 stars$21.74-0.2%$21.00-3.4%+105.0%$5.04B$860.80M-362.252,860News CoverageUpcoming EarningsAnalyst ForecastAnalyst RevisionHigh Trading VolumeSTSensata Technologies4.4076 of 5 stars$31.33-0.6%$35.50+13.3%-12.7%$4.58B$3.93B38.6819,000Positive NewsUpcoming EarningsCAMTCamtek2.5967 of 5 stars$94.29+1.9%$89.00-5.6%-13.4%$4.30B$429.23M36.13400Positive NewsOptions VolumeTRNSTranscat2.9899 of 5 stars$80.43-1.1%$112.20+39.5%-40.6%$749.61M$278.42M51.561,245 Related Companies and Tools Related Companies Adaptive Biotechnologies Alternatives Pacific Biosciences of California Alternatives Twist Bioscience Alternatives Veracyte Alternatives Vontier Alternatives Ralliant Alternatives Mirion Technologies Alternatives Sensata Technologies Alternatives Camtek Alternatives Transcat Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TXG) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 10x Genomics Please log in to your account or sign up in order to add this asset to your watchlist. Share 10x Genomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TXG Stock Alerts